(Q39789227)

English

Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen

scientific article published on 8 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Andreas Wieland

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Petra Riedl

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Jörg Reimann

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Reinhold Schirmbeck

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

8 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

114-119

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Mechanisms of MHC class I-restricted antigen processing and cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Epitope dominance, competition and T cell affinity maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Competition between MHC class I alleles for cell surface expression alters CTL responses to influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Immunodominance in TCD8+ responses to viruses: cell biology, cellular immunology, and mathematical models

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

The immune response during hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein-capturing, viral J-domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Have we cut ourselves too short in mapping CTL epitopes?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Distinct, cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Noncovalent association with stress protein facilitates cross-priming of CD8+ T cells to tumor cell antigens by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Recombinant complexes of antigen with stress proteins are potent CD8 T-cell-stimulating immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Stealth and cunning: hepatitis B and hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.096

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.09.096

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39789227&oldid=2090409796"